Literature DB >> 26627240

Secondary PDZ domain-binding site on class B plexins enhances the affinity for PDZ-RhoGEF.

Heath G Pascoe1, Stephen Gutowski1, Hua Chen1, Chad A Brautigam2, Zhe Chen2, Paul C Sternweis1, Xuewu Zhang3.   

Abstract

PDZ domains are abundant protein interaction modules and typically recognize a short motif at the C terminus of their ligands, with a few residues in the motif endowing the binding specificity. The sequence-based rules, however, cannot fully account for the specificity between the vast number of PDZ domains and ligands in the cell. Plexins are transmembrane receptors that regulate processes such as axon guidance and angiogenesis. Two related guanine nucleotide exchange factors (GEFs), PDZ-RhoGEF and leukemia-associated RhoGEF (LARG), use their PDZ domains to bind class B plexins and play critical roles in signaling. Here, we present the crystal structure of the full-length cytoplasmic region of PlexinB2 in complex with the PDZ domain of PDZ-RhoGEF. The structure reveals that, in addition to the canonical C-terminal motif/PDZ interaction, the 3D domain of PlexinB2 forms a secondary interface with the PDZ domain. Our biophysical and cell-based assays show that the secondary interface contributes to the specific interaction between plexin and PDZ-RhoGEF and to signaling by plexin in the cell. Formation of secondary interfaces may be a general mechanism for increasing affinity and specificity of modular domain-mediated interactions.

Entities:  

Keywords:  PDZ; plexin; protein interaction module; signaling; specificity

Mesh:

Substances:

Year:  2015        PMID: 26627240      PMCID: PMC4672773          DOI: 10.1073/pnas.1508931112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Assembly of cell regulatory systems through protein interaction domains.

Authors:  Tony Pawson; Piers Nash
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling.

Authors:  Jon C D Houtman; Patrick H Brown; Brent Bowden; Hiroshi Yamaguchi; Ettore Appella; Lawrence E Samelson; Peter Schuck
Journal:  Protein Sci       Date:  2007-01       Impact factor: 6.725

Review 3.  Structures and target recognition modes of PDZ domains: recurring themes and emerging pictures.

Authors:  Fei Ye; Mingjie Zhang
Journal:  Biochem J       Date:  2013-10-01       Impact factor: 3.857

4.  Activated RhoA binds to the pleckstrin homology (PH) domain of PDZ-RhoGEF, a potential site for autoregulation.

Authors:  Zhe Chen; Frank Medina; Mu-ya Liu; Celestine Thomas; Stephen R Sprang; Paul C Sternweis
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

5.  Structural basis for semaphorin signalling through the plexin receptor.

Authors:  Terukazu Nogi; Norihisa Yasui; Emiko Mihara; Yukiko Matsunaga; Masanori Noda; Naoya Yamashita; Toshihiko Toyofuku; Susumu Uchiyama; Yoshio Goshima; Atsushi Kumanogoh; Junichi Takagi
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962

6.  Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization.

Authors:  Yuxiao Wang; Huawei He; Nishi Srivastava; Sheikh Vikarunnessa; Yong-bin Chen; Jin Jiang; Christopher W Cowan; Xuewu Zhang
Journal:  Sci Signal       Date:  2012-01-17       Impact factor: 8.192

7.  Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.

Authors:  Hiroki Chikumi; Ana Barac; Babak Behbahani; Yuan Gao; Hidemi Teramoto; Yi Zheng; J Silvio Gutkind
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Structural basis of semaphorin-plexin signalling.

Authors:  Bert J C Janssen; Ross A Robinson; Francesc Pérez-Brangulí; Christian H Bell; Kevin J Mitchell; Christian Siebold; E Yvonne Jones
Journal:  Nature       Date:  2010-09-26       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  5 in total

Review 1.  Structure function relations in PDZ-domain-containing proteins: Implications for protein networks in cellular signalling.

Authors:  G P Manjunath; Praveena L Ramanujam; Sanjeev Galande
Journal:  J Biosci       Date:  2018-03       Impact factor: 1.826

2.  Functional interplay between protein domains in a supramodular structure involving the postsynaptic density protein PSD-95.

Authors:  Louise Laursen; Elin Karlsson; Stefano Gianni; Per Jemth
Journal:  J Biol Chem       Date:  2019-12-12       Impact factor: 5.157

3.  Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex.

Authors:  Defen Lu; Guijun Shang; Xiaojing He; Xiao-Chen Bai; Xuewu Zhang
Journal:  Nat Commun       Date:  2021-05-26       Impact factor: 17.694

4.  Structure analyses reveal a regulated oligomerization mechanism of the PlexinD1/GIPC/myosin VI complex.

Authors:  Guijun Shang; Chad A Brautigam; Rui Chen; Defen Lu; Jesús Torres-Vázquez; Xuewu Zhang
Journal:  Elife       Date:  2017-05-24       Impact factor: 8.140

5.  Regulation of the endosomal SNX27-retromer by OTULIN.

Authors:  Aurelia Stangl; Paul R Elliott; Adan Pinto-Fernandez; Sarah Bonham; Luke Harrison; Annalisa Schaub; Kerstin Kutzner; Kirstin Keusekotten; Paul T Pfluger; Farid El Oualid; Benedikt M Kessler; David Komander; Daniel Krappmann
Journal:  Nat Commun       Date:  2019-09-20       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.